Facilitation of L-type calcium currents by diastolic depolarization in cardiac cells: impairment in heart failure

Cardiovasc Res. 2000 Aug;47(2):336-49. doi: 10.1016/s0008-6363(00)00107-3.

Abstract

Objective: Decay kinetics of the voltage-gated L-type Ca(2+) current (I(CaL)) control the magnitude of Ca(2+) influx during the cardiac action potential. We investigated the influence of changes in diastolic membrane potential on I(CaL) decay kinetics in cardiac cells.

Methods: Cells were isolated enzymatically from rat ventricles, human right atrial appendages obtained during corrective heart surgery and left ventricles from end-stage failing hearts of transplant recipients. The whole-cell patch-clamp technique was used to evoke I(CaL) by a 100-ms depolarizing test pulse to -10 mV. Conditioning potentials between -80 and 0 mV were applied for 5 s prior to the test pulse.

Results: Depolarizing the cells between -80 and -50 mV prior to the test pulse slowed the early inactivation of I(CaL) both in rat ventricular and human atrial cells. This slowing resulted in a significant increase of Ca(2+) influx. This type of facilitation was not observed when the sarcoplasmic reticulum (SR) Ca(2+) content was depleted using ryanodine which reduced the rate of inactivation of I(CaL), or when Ba(2+) replaced Ca(2+) as the permeating ion. Facilitation was favored by intracellular cAMP-promoting agents that, in addition to increasing current peak amplitude, enhanced the fast Ca(2+)-dependent inactivation of I(CaL). Facilitation was impaired in atrial and ventricular human failing hearts.

Conclusion: Decay kinetics of I(CaL) are regulated by the diastolic membrane potential in rat and human cardiomyocytes. This regulation, which associates slowing of I(CaL) inactivation with reduced SR Ca(2+) release and underlies facilitation of Ca(2+) channels activity, may have profound physiological relevance for catecholamines enhancement of Ca(2+) influx. It is impaired in failing hearts, possibly due to lowered SR Ca(2+) release.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adrenergic beta-Agonists / pharmacology
  • Adult
  • Aged
  • Animals
  • Barium / pharmacology
  • Bucladesine / pharmacology
  • Calcium / metabolism
  • Calcium Channel Blockers / pharmacology
  • Calcium Channels, L-Type / drug effects
  • Calcium Channels, L-Type / metabolism*
  • Cyclic AMP-Dependent Protein Kinases / metabolism
  • Diastole
  • Electric Stimulation
  • Heart Atria
  • Heart Failure / metabolism*
  • Heart Ventricles
  • Humans
  • Isoproterenol / pharmacology
  • Membrane Potentials
  • Middle Aged
  • Myocardium / metabolism*
  • Patch-Clamp Techniques
  • Rats
  • Rats, Inbred WKY
  • Ryanodine / pharmacology
  • Sarcolemma / drug effects
  • Sarcolemma / metabolism
  • Serotonin / pharmacology

Substances

  • Adrenergic beta-Agonists
  • Calcium Channel Blockers
  • Calcium Channels, L-Type
  • Ryanodine
  • Barium
  • Serotonin
  • Bucladesine
  • Cyclic AMP-Dependent Protein Kinases
  • Isoproterenol
  • Calcium